Related Experiment Video
Updated: Jan 27, 2026

Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
Published on: January 24, 2025
Resveratrol Anti-Obesity Effects: Rapid Inhibition of Adipocyte Glucose Utilization
Christian Carpéné1,2, Francisco Les3,4, Guillermo Cásedas5
1Institute of Metabolic and Cardiovascular Diseases, INSERM, UMR1048, Team 1, 31342 Toulouse, France. christian.carpene@inserm.fr.
Abstract:
Studies in animal models of diabetes and obesity have shown that resveratrol mitigates complications of metabolic diseases, beyond those resulting from oxidative stress. Furthermore, results obtained with cultured preadipocytes have also revealed that prolonged resveratrol treatment impairs adipogenesis. Considering the role of adipocytes in the hypertrophy of fat stores, and keeping in mind that insulin is the main trigger of excessive energy storage during post-prandial periods, the present study aimed to investigate how short-term effects of resveratrol can limit glucose disposal in a gut-adipose tissue axis. We found that resveratrol exhibits a more potent inhibitory capacity towards α-glucosidase than pancreatic lipase activity. Resveratrol also rapidly blunts glucose transport in mature fat cells by counteracting the effect of insulin and insulin-like lipogenic agents. Within two hours, resveratrol also inhibited the incorporation of glucose into lipids of adipocytes, which was unaffected by membrane cholesterol depletion. Moreover, the comparison between adipocytes with invalidated semicarbazide-sensitive amine oxidase activity and their control, or between resveratrol and several inhibitors, did not indicate that the recently described interaction of resveratrol with amine oxidases was involved in its antilipogenic effect. Caffeine and piceatannol, previously said to interact with glucose carriers, also inhibit lipogenesis in adipocytes, whereas other antioxidant phytochemicals do not reproduce such an antilipogenic effect. This study highlights the diverse first steps by which resveratrol impairs excessive fat accumulation, indicating that this natural molecule and its derivatives deserve further studies to develop their potential anti-obesity properties.
Insights
Resveratrol rapidly limits glucose uptake and fat accumulation in adipocytes by counteracting insulin
Area of Science:
- Metabolic Science
- Nutritional Biochemistry
- Pharmacology
Background:
- Resveratrol shows promise in mitigating metabolic disease complications in animal models.
- Prolonged resveratrol treatment in preadipocytes impairs adipogenesis.
- Adipocytes play a key role in fat storage, influenced by insulin during post-prandial periods.
Purpose of the Study:
- To investigate the short-term effects of resveratrol on glucose disposal within the gut-adipose tissue axis.
- To understand how resveratrol limits glucose uptake and lipid incorporation in adipocytes.
- To explore the mechanisms underlying resveratrol's antilipogenic effects.
Main Methods:
- Assessed resveratrol's inhibitory capacity against α-glucosidase and pancreatic lipase.
- Examined resveratrol's effect on glucose transport in mature adipocytes, including its interaction with insulin.
- Investigated resveratrol's inhibition of glucose incorporation into lipids and its relation to membrane cholesterol.
- Evaluated the role of semicarbazide-sensitive amine oxidase activity and compared resveratrol with other phytochemicals.
Main Results:
- Resveratrol potently inhibits α-glucosidase activity more than pancreatic lipase.
- Resveratrol rapidly reduces glucose transport in adipocytes, counteracting insulin and insulin-like lipogenic agents.
- Resveratrol inhibits glucose incorporation into adipocyte lipids within two hours, independent of membrane cholesterol.
- Resveratrol's antilipogenic effect is not mediated by semicarbazide-sensitive amine oxidases.
- Caffeine and piceatannol also inhibit adipocyte lipogenesis, unlike other antioxidant phytochemicals.
Conclusions:
- Resveratrol exhibits multiple early mechanisms to impede excessive fat accumulation.
- Resveratrol's potent inhibition of glucose uptake and lipid synthesis in adipocytes suggests anti-obesity potential.
- Further research into resveratrol and its derivatives is warranted for developing anti-obesity therapeutics.
More Related Videos
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Related Concept Videos
Obesity
Feedback Inhibition
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Drug Dosing: Obese Patients